BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6109057)

  • 1. Oxyfedrine.
    Lancet; 1981 Jan; 1(8210):25-6. PubMed ID: 6109057
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect on the A-V conduction of a new antianginal drug: oxyphedryne.
    Zagatti G; Benzoni A; Caturelli G
    Boll Soc Ital Cardiol; 1977; 22(2):189-96. PubMed ID: 618204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary observations on the use of oxyfedrine in the therapy of angina pectoris].
    Di Lorenzo M; Puddu V
    Minerva Cardioangiol; 1975 Jan; 23(1):3-6. PubMed ID: 806853
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of oxyfedrine and propranolol in angina pectoris].
    Chaĭtington DzhR ; Refteri EB
    Ter Arkh; 1980; 52(5):59-62. PubMed ID: 6996188
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experiences with oxyfedrine in patients with angina pectoris.
    Raftery EB; Whittington JR
    Herz; 1982 Dec; 7(6):358-65. PubMed ID: 6761258
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxyfedrine as an antianginal agent.
    Parratt JR
    Lancet; 1981 Feb; 1(8217):441. PubMed ID: 6110066
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind cross-over clinical trial of oxyfedrine in angina pectoris.
    Mohindra S; Sharma PL; Wahi PL
    J Assoc Physicians India; 1972 Nov; 20(11):829-35. PubMed ID: 4144031
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
    Puri VK; Agarwal SK; Mehrotra A; Hasan M
    Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of oxyfedrine and atenolol in angina pectoris--a double-blind study.
    Fananapazir L; Bray C
    Br J Clin Pharmacol; 1985 Oct; 20(4):405-10. PubMed ID: 3907677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new coronary cardio-active compound in angina pectoris.
    Kundu SC; De TK; Majumdar S; Bhattacherjee TD; Mukerjee AB
    J Indian Med Assoc; 1975 Sep; 65(5):136-43. PubMed ID: 765401
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris.
    Sagar S; Pandhi P; Anand IS; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):186-9. PubMed ID: 3888857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of oxyfedrine on myocardial infarct size following coronary artery occlusion in rats (author's transl)].
    Chiariello M; Brevetti G; Petillo F; Ferro G; Giasi M; Condorelli M
    G Ital Cardiol; 1981; 11(3):373-9. PubMed ID: 6116640
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxyfederine and propranolol--a controlled trial in angina pectoris.
    Whittington J; Raftery EB
    Br J Clin Pharmacol; 1980 Nov; 10(5):439-42. PubMed ID: 7437255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients].
    Schieffer H; Sternitzke N
    Fortschr Med; 1984 May; 102(19):551-6. PubMed ID: 6429021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxyphedrine: its positive inotropic action in normal subjects and in patients with myocardial infarct].
    Jacono A; Iarussi D; Casaburi U
    Minerva Cardioangiol; 1975 Sep; 23(9):571-5. PubMed ID: 1161166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oxyfedrine in coronary therapy].
    Wallner H; Sternitzke N; Schieffer H
    ZFA (Stuttgart); 1980 Mar; 56(9 Suppl):612-6. PubMed ID: 7234092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

  • 19. [Positive inotropic effect of coronary-active drug: oxyfedrine].
    Conti G; Moreschini G; Pelosi M
    Minerva Cardioangiol; 1980 Sep; 28(9):645-7. PubMed ID: 7465070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of coronaroactive agents with beta-stimulating effect in ischemic heart disease].
    Kukes VG; Buianov VV; Semenov VN; Abugov AM; Borovkov AI
    Kardiologiia; 1976 Apr; 16(4):88-93. PubMed ID: 16157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.